Oncolytics Biotech Inc.
ONCY | NASDAQ
$0.74
-$0.03 (-3.43%)
Sep 22, 2026, 12:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -28.73M | -25.54M | -25.47M | -19.84M | -26.23M | -25.46M |
Interest Income | 529.64K | 1.2M | 1.33M | 528K | n/a | 90.36K |
Pretax Income | -28.68M | -22.7M | -20.85M | -18.24M | -26.26M | -22.51M |
Net Income | -28.76M | -22.79M | -20.92M | -18.3M | -26.3M | -22.51M |
Selling & General & Admin | 15.41M | 10.1M | 11.82M | 8.18M | 12.86M | 12.51M |
Research & Development | 13.31M | 15.44M | 13.35M | 11.37M | 12.92M | 12.95M |
Other Expenses | n/a | n/a | 303.78K | 288.83K | 451.95K | n/a |
Operating Expenses | 28.73M | 25.54M | 25.47M | 19.84M | 26.23M | 25.46M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.73M | 25.54M | 25.47M | 19.84M | 26.23M | 25.46M |
Income Tax Expense | 79K | 95K | 73.12K | 61.89K | 49K | n/a |
Shares Outstanding (Basic) | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M | 40.34M |
Shares Outstanding (Diluted) | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M | 40.34M |
EPS (Basic) | -0.41 | -0.30 | -0.41 | -0.44 | -0.49 | -0.48 |
EPS (Diluted) | -0.41 | -0.30 | -0.41 | -0.44 | -0.49 | -0.48 |
EBITDA | -28.66M | -25.46M | -25.17M | -19.55M | -25.78M | -25.37M |
EBIT | -28.73M | -25.54M | -25.47M | -19.84M | -26.24M | -25.46M |
Depreciation & Amortization | 70K | 87K | 303.78K | 288.83K | 452K | 89K |
Add to Watchlist
Select watchlists to add or remove ONCY